Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu

Nantes 44093 Cedex 1

3 studies enrolling now · 9 studies all time

What they study most

Alopecia, Areata Alopecia, Atopic Dermatitis, B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hair Diseases, Hypotrichosis, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-cell Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin, Mantle Cell Lymphoma

Studies at this site

• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) — Recruiting now
• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata — Recruiting now
• A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant — Recruiting now
• Study of Oral LOXO-338 in Patients With Advanced Blood Cancers — Completed
• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus — Stopped early
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed